Jafron Biomedical Co.,Ltd.

Shenzhen Stock Exchange 300529.SZ

Jafron Biomedical Co.,Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 12.23%

Jafron Biomedical Co.,Ltd. Return on Capital Employed (ROCE) is 12.23% for the year ending December 31, 2023, a -45.49% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

Jafron Biomedical Co.,Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 22.43%, a -30.21% change year over year.
Jafron Biomedical Co.,Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 32.14%, a -10.24% change year over year.
Jafron Biomedical Co.,Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 35.80%, a 19.01% change year over year.
Jafron Biomedical Co.,Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 30.09%, a 12.71% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

Shenzhen Stock Exchange: 300529.SZ

Jafron Biomedical Co.,Ltd.

CEO	Mr. Fan Dong
IPO Date	Aug. 2, 2016
Location	China
Headquarters	No. 98 Keji 6th Road
Employees	2,408
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials Medical Instruments

Description

Jafron Biomedical Co.,Ltd. engages in the research, development, production, and marketing of biological materials and medical devices in China. It offers solutions for kidney, liver, critical, and rheumatism diseases, as well as poisoning; adsorption products and blood purification machines; and other products, such as single use arteriovenous puncture, hemodialysis online dry powder bags/cylinders, disinfectants, hemodialysis concentrates, and medical adsorbable suture with needles. The company offers its products in Germany, Italy, Turkey, Thailand, Vietnam, the Philippines, South Africa, Kenya, Chile, Peru, and the United Arab Emirates. Jafron Biomedical Co.,Ltd. was founded in 1989 and is based in Zhuhai, China.

Key trends

Past 5 years